Newborn Jaundice in India: Causes, Phototherapy and When to Worry

• Jaundice that appears after 24 hours, peaks around day 3-5 and fades within 1-2 weeks in a feeding, alert baby is usually physiological and harmless.
• Jaundice in the first 24 hours of life is always abnormal until proven otherwise and needs same-day assessment.
• Eyeballing the yellow colour is unreliable — every newborn should have a transcutaneous or blood bilirubin reading before discharge and a follow-up within 1-3 days.
• Phototherapy (blue LED light) is the safe, effective first-line treatment; exchange transfusion is reserved for severe cases.
• Red flags: a very sleepy baby who won't feed, high-pitched cry, arched back, fewer wet diapers, pale stools with dark urine, or jaundice spreading to the soles.
• Treated in time, almost every baby recovers fully. Kernicterus (brain damage) is now rare in India when screening and thresholds are followed.

Jaundice is the yellow tint that appears in the skin and the whites of the eyes when bilirubin — a yellow-orange pigment released when red blood cells break down — builds up faster than the liver can clear it. Babies are born with a high red cell count (useful in the lower-oxygen womb), and those extra cells start breaking down within hours of birth. That creates a large bilirubin load for a liver whose clearing enzymes are still maturing in the first 3-5 days, so bilirubin temporarily accumulates and the skin looks yellow. This is physiological jaundice. It typically appears on day 2-3, peaks around day 3-5 in term babies (a little later in preterm babies), and fades by 1-2 weeks.

Indian babies carry some specific risk factors. G6PD deficiency, an inherited enzyme problem that makes red cells break down faster, is more common in several Indian communities and can trigger sudden, severe jaundice — especially after exposure to naphthalene mothballs, certain drugs, or some traditional preparations. Blood group incompatibility is another important cause: ABO incompatibility (mother O, baby A or B) or Rh incompatibility (mother Rh-negative, baby Rh-positive). Prematurity, low birth weight, a sibling who had severe jaundice, poor latch leading to inadequate intake, bruising at birth (cephalhematoma) and infection all raise the risk. Spotting these early is part of a standard newborn check, much like the routine newborn screening heel-prick test.

Visible yellow appears once bilirubin reaches roughly 5 mg/dL, spreading head-to-toe — face first, then chest, abdomen, thighs and finally the soles. This pattern is a rough guide (jaundice reaching the soles usually means a higher level), but it is unreliable in deeper skin tones, in artificial light and in quick clinic checks. That is why Indian nurseries now confirm severity with a transcutaneous bilirubinometer (a painless device pressed to the forehead or chest) or a blood bilirubin test before deciding anything. Judging by eye alone is no longer the standard — and neither parents nor relatives should rely on it in the first week.

Physiological jaundice follows a predictable pattern: it appears after the first 24 hours, stays at moderate levels, fades by 1-2 weeks in term babies (2-3 weeks in preterm babies), and comes with no other signs of illness. The baby feeds well, passes urine and stool, is alert when awake, and starts regaining weight after the normal day-3 dip. The bilirubin stays below treatment thresholds, so the only "treatment" is good feeding, observation and a routine bilirubin check before or just after discharge.

Pathological jaundice is suspected when any red flag appears: jaundice within the first 24 hours of life (always abnormal until proven otherwise); a fast rise (more than about 0.2 mg/dL per hour, or 5 mg/dL per day); bilirubin crossing the phototherapy or exchange threshold for the baby's age; jaundice persisting beyond 2 weeks in a term baby or 3 weeks in a preterm baby; pale stools with dark urine (a warning for biliary atresia, which needs surgery before 60 days); jaundice with fever, lethargy or feeding refusal; or jaundice in a baby with known Rh/ABO incompatibility or significant bruising. Any of these triggers a fuller workup — direct (conjugated) bilirubin, complete blood count, peripheral smear, Coombs test, mother and baby blood groups, and, depending on findings, a G6PD assay, thyroid screen or infection screen.

A practical Indian point: "mild" jaundice and "no concern" jaundice are not the same thing. Even physiological jaundice can climb if the baby is feeding poorly, getting dehydrated, or has an unrecognised risk factor. This is exactly why the AAP 2022 and IAP guidelines both stress a bilirubin reading before discharge and a follow-up check within 24-72 hours — especially for babies sent home before 48 hours. Private chains build this into discharge; under the government's Navjaat Shishu Suraksha Karyakram and Janani Shishu Suraksha Karyakram, predischarge screening plus an early ASHA or ANM home visit are part of the package, alongside the rest of first-week newborn care.

Most parents will see some yellow tinge in the first week and wonder whether it is normal. The signs below mean the baby needs urgent assessment — ideally within hours, not the next day. Jaundice appearing in the first 24 hours of life is always abnormal. So is yellow spreading down to the abdomen, thighs or soles by day 3-4 in a term baby, which suggests a high level.

Treat it as an emergency if the baby is very sleepy and hard to wake even for feeds, is feeding much less than usual, has a high-pitched cry, arches the back, has stiff or floppy muscle tone, develops a fever, or has had no wet diaper for 6-8 hours. These can be early signs of acute bilirubin encephalopathy — the brain-affecting stage that precedes kernicterus. Tracking nappies helps here; our guide to how baby poop colour and consistency change explains what normal output looks like.

Pale, chalky stools (instead of normal yellow or greenish) together with dark yellow-brown urine are a red flag for biliary atresia, a blocked bile-duct condition that needs a Kasai operation before 60 days for the best outcome. Major Indian pediatric centres perform this surgery, and guidelines recommend checking direct bilirubin in any baby whose jaundice lasts beyond 2 weeks (term) or 3 weeks (preterm). For the baby specifically, the right calls are your pediatrician, 108 for free emergency transport if getting there is the obstacle, or the nearest pediatric emergency room. Do not wait for jaundice to "go down on its own" if any of these signs is present — and don't confuse this with a baby who simply spits up or has reflux, which is a separate, usually benign issue.

Phototherapy is the first-line treatment once bilirubin crosses the age-specific threshold. Blue light at a specific wavelength (around 460-490 nm) penetrates the skin and converts bilirubin into a water-soluble form the baby can excrete in urine and stool without relying on the liver. Modern units use LED lights that are efficient, generate little heat and are safer than the older fluorescent tubes still seen in some smaller hospitals. The baby lies under the light in just a diaper, with soft padded patches protecting the eyes. Feeding continues normally — the baby comes out every 2-3 hours to breastfeed, and skin-to-skin can resume between sessions in less intensive cases.

In hospital, phototherapy usually runs continuously for 24-48 hours (longer in severe cases), with bilirubin checks every 6-12 hours and close watch on hydration (urine output, weight, fontanelle). Most babies respond well, with bilirubin typically falling 2-3 mg/dL per day. In Indian private hospitals, phototherapy in the well-baby nursery costs roughly Rs 3,000-8,000 per day including bed and monitoring, while NICU-level care runs Rs 15,000-50,000 per day depending on the city and chain. Under PMJAY (Ayushman Bharat) and most state schemes this is fully covered at empanelled hospitals, and at government medical colleges and district hospitals it is free under JSSK and NSSK.

Home phototherapy is increasingly available in major Indian cities for carefully selected babies: bilirubin in the moderate range that needs treatment but not NICU monitoring, an otherwise stable baby, a family able to support the device, and a pediatrician arranging close follow-up. Home-care providers rent LED units for roughly Rs 2,000-5,000 per day all-inclusive (delivery, installation, daily bilirubin check and equipment return). It is convenient and lowers hospital-infection risk, but it suits only the right cases — the pediatrician decides based on bilirubin level, rate of rise, age in hours and individual risk factors. Phototherapy is not a reason to stop nursing; if anything, good breastfeeding positions and latch help clear bilirubin faster.

The American Academy of Pediatrics updated its hyperbilirubinemia guideline in 2022, and Indian practice broadly follows these thresholds with local adaptation. The thresholds are not single numbers — they are nomograms (charts) that plot bilirubin against the baby's age in hours and the presence of risk factors. A chart is used because the safe level shifts by the hour: a bilirubin of 12 mg/dL at 24 hours is concerning, while the same 12 mg/dL at 96 hours may sit well within the normal range. Your pediatrician uses the nomogram to decide between phototherapy, exchange transfusion, closer monitoring, or routine follow-up.

As broad guideposts (not a substitute for individual assessment): for a term baby with no risk factors, phototherapy is typically started around 15 mg/dL at 24 hours, 18 at 48 hours, 20 at 72 hours, and 21-22 after 96 hours. Exchange transfusion is considered at much higher levels (roughly 20-25 mg/dL, depending on age and risk). For a preterm baby or one with risk factors — G6PD deficiency, ABO/Rh incompatibility, sepsis, low albumin — the thresholds are lower: phototherapy may begin at 12-15 mg/dL and exchange be considered at 17-20 mg/dL. The exact numbers should always be read off the current nomogram by the pediatrician, not from a single figure online.

Two things to know about the modern guideline. First, the thresholds are slightly more permissive than older versions, so phototherapy is started a little higher — this reduces unnecessary treatment. Second, the approach is individualised, weighing risk factors and an hour-specific chart. In the Indian setting, identifying risk factors such as G6PD deficiency, blood group incompatibility (often picked up on routine pregnancy blood tests) and prematurity matters even more because some of these are commoner here. The practical message for parents: don't be alarmed if your pediatrician quotes a slightly different threshold than something you read online — a number that looks high may be safe for your baby's specific age, while a number that looks reassuring may still warrant treatment in a preterm or high-risk baby.

When bilirubin reaches very high levels despite intensive phototherapy, or is already severe at presentation, exchange transfusion is the next step. Small portions of the baby's blood are removed and replaced with donor blood through an umbilical catheter, gradually exchanging about twice the baby's blood volume over 2-4 hours. This rapidly removes a large amount of bilirubin and also clears the antibodies driving red cell breakdown in Rh or ABO incompatibility. It is done in the NICU under continuous monitoring and is considered relatively safe in experienced hands, though it carries its own risks (infection, electrolyte shifts, mechanical complications).

The threshold uses the same nomogram framework as phototherapy. For a healthy term baby it may be around 22-25 mg/dL at 24-48 hours, easing somewhat at later ages; for preterm or high-risk babies it can be as low as 17-20 mg/dL. The decision also factors in the bilirubin-to-albumin ratio, because bilirubin bound to albumin is far less likely to cross into the brain than free bilirubin. Any sign of acute bilirubin encephalopathy — lethargy, abnormal muscle tone, high-pitched cry, arching of the back — is itself an indication for exchange, whatever the exact number.

In Indian private NICUs, exchange transfusion costs roughly Rs 25,000-75,000 including donor blood, the procedure and the surrounding NICU stay; at PMJAY-empanelled and government tertiary centres it is free. Blood is matched and sourced from the hospital blood bank, and most large cities have a centre experienced in the procedure. Reassuringly, with the 2022 thresholds and modern phototherapy the need for exchange transfusion has fallen sharply — most significant jaundice is now controlled by phototherapy alone.

Kernicterus is irreversible brain damage that can occur when very high bilirubin crosses into the brain and deposits in specific regions. Its acute phase, acute bilirubin encephalopathy, shows up as progressive sleepiness, poor feeding, changing muscle tone, a high-pitched cry, arching of the back, and in severe cases seizures or pauses in breathing. If bilirubin is brought down quickly at this stage (intensive phototherapy plus exchange transfusion), many babies recover; if it progresses, the damage becomes permanent — a movement-disorder form of cerebral palsy, hearing loss (especially high-frequency), eye-movement problems and dental enamel defects. Affected children usually have normal intelligence but lifelong motor and sensory difficulties.

Kernicterus is now rare in India when standard predischarge screening, age-specific thresholds and timely treatment are followed. The cases that still occur tend to share a gap: babies discharged early without a bilirubin check, babies born without follow-up, unrecognised G6PD deficiency or blood group incompatibility, families assuming jaundice will fade and delaying their return, or biliary atresia mistaken for ordinary jaundice. National newborn programmes target exactly these gaps through screening, follow-up visits and family education, and the 102 Janani Express service provides free transport for sick newborns in most states.

The core message: kernicterus is preventable. Every baby should have at least one bilirubin reading before discharge, a follow-up within 1-3 days, prompt attention to any danger sign, and a low threshold for a recheck if jaundice is worsening or feeding is poor. Don't skip the predischarge bilirubin even if the baby looks well — many severe cases were "fine" at discharge and turned up on day 4-5 with very high levels. Don't refuse phototherapy over the small inconveniences of eye patches or a few days in hospital; the alternative is permanent disability. And don't let home remedies — sunlight on the chest, gripe water, boiled leaves — delay real care, because they have no role in significant jaundice.

Breastfeeding jaundice and breast milk jaundice sound alike but are different. Breastfeeding jaundice appears in the first week (days 2-7) and is caused by inadequate milk intake — poor latch, infrequent feeds, a sleepy baby who isn't waking, or a supply that hasn't fully come in yet. Less intake means fewer stools, so bilirubin that should leave in the stool gets reabsorbed instead. The fix is more breastfeeding, not less: frequent feeds every 2-3 hours including night feeds, a good latch (an IBCLC lactation consultant or hospital lactation nurse can help — see how to troubleshoot common latch problems), and occasionally short-term supplementation if weight loss exceeds 10 percent or jaundice keeps rising. If supply is the worry, our guide to the causes of low milk supply is a useful next read.

Breast milk jaundice is a separate, later entity. It appears in week 2-3, can persist for several weeks (sometimes up to 12), and is thought to involve factors in breast milk that slow bilirubin excretion. The baby feeds well, gains weight normally, has normal stools and urine, and is otherwise completely well; the bilirubin is unconjugated and not high enough to harm. It is a diagnosis of exclusion — biliary atresia, infection, hypothyroidism and metabolic conditions must first be ruled out. Once confirmed, the management is simply to keep breastfeeding and reassure the family; the jaundice fades over weeks with no specific treatment.

Indian families sometimes fear breastfeeding is "causing" the jaundice and stop — almost always the wrong move. For breastfeeding jaundice the answer is more feeding; for breast milk jaundice in a thriving baby, breastfeeding should continue. Only rarely, in stubborn high-level cases where everything else is excluded, may a pediatrician suggest a brief 24-48 hour pause (with pumping to protect supply) as a diagnostic test — and even that is uncommon today. If a baby goes through a phase of refusing the breast during all this, support is available; the goal is to keep the baby well-fed while jaundice is managed.

The cost of treating newborn jaundice in India varies hugely by pathway — but effective care exists across the price spectrum, and no family should let cost delay care for a baby with significant jaundice. Government pathway: under the Navjaat Shishu Suraksha Karyakram, Janani Shishu Suraksha Karyakram, Rashtriya Bal Swasthya Karyakram and Mission Indradhanush, sick-newborn care — phototherapy, exchange transfusion, NICU admission and follow-up — is provided free at government facilities, from PHCs and CHCs up to district hospitals and medical colleges. Transport is free under the 102 Janani Express scheme, and predischarge screening plus ASHA home visits are part of the standard package. For most families in smaller cities and rural areas this is the right first pathway and is medically excellent at major government tertiary centres.

PMJAY (Ayushman Bharat) pathway: eligible families can access NICU care, phototherapy and exchange transfusion at empanelled private hospitals free, up to the annual cover of Rs 5 lakh per family. Many major chains are empanelled and can provide the full range of newborn care without out-of-pocket cost for those who qualify, covering the typical 3-7 day NICU stay severe jaundice can need.

Private pathway (out-of-pocket): well-baby nursery phototherapy runs about Rs 3,000-8,000 per day; NICU phototherapy Rs 15,000-50,000 per day; exchange transfusion Rs 25,000-75,000; home phototherapy Rs 2,000-5,000 per day all-inclusive. A typical moderate case managed in the well-baby nursery for 2-3 days comes to roughly Rs 10,000-30,000, while severe jaundice needing 5-7 days of NICU can reach Rs 1.5-4 lakh. Private health insurance generally covers newborn NICU admission, but read the policy: since IRDAI standardised newborn cover in maternity policies, most plans include it, though details still vary by insurer, so confirm whether the baby is covered from birth under the mother's policy.

The practical decision is usually urgent, so the rule is simple: do not delay assessment over cost uncertainty. Take the baby to the nearest appropriate facility first — the 108 ambulance is free, government hospitals are free, PMJAY hospitals are free for eligible families, and private hospitals will not turn away a sick baby. Sort out billing during or after admission with the hospital billing desk, the insurance helpdesk, the PMJAY helpdesk or the hospital's medical social worker, who can help access government schemes and charity support. The stress of a sick newborn is real; if you are struggling emotionally, our guide to postpartum depression and when it is more than the baby blues and the 1097 helpline can help.

After discharge for jaundice — with or without phototherapy — a follow-up bilirubin and clinical check matters. Babies treated with phototherapy should have a recheck within 24-48 hours of stopping it to confirm there is no rebound. Jaundice lasting beyond 2 weeks (term) or 3 weeks (preterm) needs a direct bilirubin measurement to exclude biliary atresia. Babies who had significant jaundice with risk factors should have a newborn hearing test at around 3 months to detect any auditory damage. A baby found to have G6PD deficiency needs lifelong avoidance of trigger drugs and substances and family screening; one with blood group incompatibility may need a hemoglobin check at 6-8 weeks for late anemia, and the mother may need anti-D in future Rh-negative pregnancies.

Long-term outcomes are excellent for the vast majority treated in time — modern phototherapy and selective exchange transfusion mean almost all babies recover with normal development. The small minority who develop kernicterus may have permanent motor disability and hearing loss, but cognition is typically normal and, with the right support, these children lead full educational and social lives. Early-identification programmes like RBSK and district rehabilitation services exist to help, though access varies by region.

The reassuring takeaway: jaundice is common, the system has clear thresholds and protocols, treatment works when it is timely, and the long-term outcome is normal for almost every baby. The stressful first week of lights, blood tests and worry passes. Your part is straightforward — trust the pediatrician's threshold decisions (don't ask to stop phototherapy early just because the baby seems fine), keep breastfeeding throughout unless specifically advised to pause, attend follow-up visits even if the baby looks well, and carry the same vigilance into future pregnancies. As your baby grows, our guides to baby developmental milestones and the baby vaccination schedule cover the road ahead.

• AAP Clinical Practice Guideline: Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation (2022)
• WHO — Newborn health and care of the preterm and sick newborn
• Indian Academy of Pediatrics (IAP) — Neonatal Jaundice / NNF guidance
• Ministry of Health & Family Welfare, India — Navjaat Shishu Suraksha Karyakram (NSSK) and JSSK
• National Health Authority — Ayushman Bharat PM-JAY
• NHS — Newborn jaundice